Skip to main content
KP Tissue Inc. logo

KP Tissue Inc. — Investor Relations & Filings

Ticker · KPT ISIN · CA48265Y1043 LEI · 5299002RIS0XL3CM5V11 TSX Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2021-03-11 Earnings Release
Country CA Canada
Listing TSX KPT

About KP Tissue Inc.

https://www.kptissueinc.com/home

KP Tissue Inc. operates as a holding company, with its business limited to holding an equity interest in Kruger Products Inc. Kruger Products Inc. is a producer, distributor, marketer, and seller of disposable tissue products, serving both the Consumer and Away-From-Home segments. The product portfolio includes bathroom tissue, facial tissue, paper towels, and napkins. Kruger Products is recognized as the leading supplier of tissue products by overall dollar and volume market share, primarily serving the Canadian market while also maintaining operations in the United States.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a press release announcing Docebo's financial results for the fourth quarter and fiscal year ended December 31, 2020. It includes detailed financial highlights such as revenue, net loss, adjusted EBITDA, cash flow, and other key performance indicators. The document also mentions a conference call to discuss these results and references the filing of audited financial statements and Management's Discussion & Analysis (MD&A) on SEDAR and EDGAR. The content is typical of an Earnings Release (ER) as it provides initial quarterly and annual financial results highlights but does not contain the full annual report or comprehensive financial statements within the text. The document length (15,000 characters) and detailed financial data support this classification. Therefore, the document is best classified as an Earnings Release (ER).
2021-03-11 English
News release - French.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a press release dated March 11, 2021, presenting detailed financial results for the fourth quarter and full year 2020 of Papiers Tissu KP and Produits Kruger S.E.C. It includes revenue figures, adjusted EBITDA, net income/loss, operational highlights, and outlook for Q1 2021. The document contains substantive financial data and analysis, including comparisons to prior periods, operational commentary, and future guidance. It is not merely an announcement of a report or a certification. The presence of detailed quarterly and annual financial results and management commentary indicates this is an Interim / Quarterly Report (IR) type document, as it covers a period shorter than a full fiscal year (quarterly) and includes comprehensive financial data and analysis. Although it also covers the full year 2020, the focus on quarterly results and the nature of the document as a press release with detailed financial results aligns best with the Interim / Quarterly Report category rather than a full Annual Report (10-K).
2021-03-11 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO of KP Tissue Inc. regarding the interim financial report and interim MD&A for the period ended September 30, 2020. It is a Form 52-109F2 certification, which is a regulatory attestation of the accuracy and completeness of interim filings. The document does not contain the interim financial statements or substantive financial data itself, but rather certifies the interim filings. The document length is 3292 characters, which is relatively short and consistent with a certification letter. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR).
2020-11-05 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO regarding the interim financial report and interim MD&A for the period ended September 30, 2020. It references National Instrument 52-109, which pertains to certification of disclosure in interim filings. The document contains no actual financial data or analysis but is a formal attestation of the accuracy and fairness of the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is short (3305 characters), and it is clearly a certification letter rather than a full interim report.
2020-11-05 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CFO of KP Tissue Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2020. The document is primarily an officer certification letter confirming the accuracy and completeness of the interim filings, including controls over financial reporting. It does not contain actual financial statements or substantive financial data itself, but rather attests to the interim filings. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is 3298 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2020-11-05 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CFO of Kruger Products L.P. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2020. The content is primarily an officer certification regarding the interim filings, controls, and procedures, without containing actual financial statements or substantive financial data. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3319 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2020-11-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.